Age-dependent deterioration of peak inspiratory flow with two kinds of dry powder corticosteroid inhalers (Diskus R and Turbuhaler R) and relationships with asthma control

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 24, Issue 6, 2011, Pages 293-301

  Baba, Kenji ^a   Tanaka, Hiroyuki ^a   Nishimura, Masaki ^a   Yokoe, Norihito ^a   Takahashi, Daisuke ^a   Yagi, Takeo ^a   Yamaguchi, Etsuro ^a   Maeda, Yuka ^b   Muto, Tatsuya ^c   Hasegawa, Takaaki ^c  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIVERSITY HOSPITAL   (Japan)

^c AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

asthma; Diskus; dry powder inhaler; In Check Dial; peak inspiratory flow; Turbuhaler

Indexed keywords

BUDESONIDE; FLUTICASONE;

ADULT; AGED; ARTICLE; ASTHMA; CORTICOSTEROID THERAPY; DETERIORATION; DISEASE CONTROL; FEMALE; FORCED EXPIRATORY VOLUME; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PEAK INSPIRATORY FLOW; POWDER INHALER; QUALITY OF LIFE;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASTHMA; DRY POWDER INHALERS; FEMALE; HUMANS; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; QUALITY CONTROL;

EID: 82955217233     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2010.0868     Document Type: Article

References (23)

1. Bannno M, Ibata H, Niimi T, Sato S, and Matsushita R: The usefulness of inspiratory flow rate during inhalation of corticosteroid therapy in asthma. Respiration. 2009;78:387-392.
2. R due to mishandling is common in clinical practice. Clin Drug Invest. 2005;25:543-549. (Pubitemid 41058454)
3. Van der Palen J: Peak inspiratory flow through discus and turbuhaler measured by means of a peak inspiratory flow meter (In-Check Dial). Respir Med. 2003;97:285-289.
4. Hill LS, Slater AL: Comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med. 1998;92:105-110. (Pubitemid 28112050)
5. Borgstrom L, Bondesson E, Moren F, Trofast E, Newman SP: Lung deposition of budesonide inhaled via Turbuhaler®: a comparison with terbutaline sulphate in normal subjects. Eur Repir J. 1994;7:69-73. (Pubitemid 24075127)
6. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, and Pendergraft TB: Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59-65. (Pubitemid 38096162)
7. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, and Jhingran P: Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117:549-556. (Pubitemid 43340217)
8. Fanny WS, Leung T-F, Hui DSC, Chu H-y, Wong GWK, Wong E, Tung AHM, and Lai CKW: Asthma control test correlates well with the treatment decisions made by asthma specialists. Respirology. 2009;14:559-566.
9. Sato R, Tomita K, Sano H, Ischihashi H, Yamagata S, Sano A, Yamagata T, Miyara T, Iwanaga T, Muaki M, and Tohda Y: The strategy for predicting future exacerbation of asthma using combination of the asthma control test and lung function test. J Asthma. 2009;46:677-682.
10. Bhalla RK, Taylor W, Jones AS, Roland NJ: The inflammation produced by corticosteroid inhalers in the pharynx in asthmatics. Clin Otolaryngol. 2008;33:581-586.
11. Bhalla RK, Jones AS, Roland NJ: Prevalence of pharyngeal and laryngeal complications in adult asthmatics using inhaled corticosteroids. J Laryngol Otol. 2008;122: 1078-1083.
12. Dubus JC, Marguest C, Deschildre A, Mely L, LeRoux P, Brouard J, Huiart L: Local sode-effects of inhaled corticosteroids in asthmatic childred: influence of drug, dose, age, and device. Allergy. 2001;56:944-948. (Pubitemid 32835598)
13. Amirav I, Newhouse MT, and Mansour Y: Measurement of peak inspiratory flow with In-Check Dial Device to simulate low-resistance (Diskus) and high-resistance (Turbuhaler) dry powder inhalers in children with asthma. Pediatric Pilmo-nol. 2005;39:447-451. (Pubitemid 40548287)
14. Olsson BO: Aerosol particle generation from dry powder inhalers; can they equal pressurized metered dose inhalers? J Aerosol Med. 1995;8(Suppl 3):S13-S19.
15. Agertoft L, Pedersen S: Lung deposition and systemic availability of fluticasone diskus and budesonide Turbuhaler in children. Am J Respir Crit Care Med. 2003;168: 779-782. (Pubitemid 37188300)
16. Nakazawa T and Dobashi K: Current asthma death among adults in Japan. Allergol Intern. 2004;53:205-209. (Pubitemid 39312315)
17. Tsukioka K, Toyabe S, and Akazawa K: Relationship between asthma severity and age at onset in Japanese adults. Nippon Kokyuki Gakkai Zasshi. 2010;48:895-905 (in Japanese).
18. Talreja N, and Baptist AP: Effect of age on asthma control: results from the National Asthma Survey. Ann Allergy Asthma Immunol. 2011;106:24-29.
19. Busse PJ, and Mathur SK: Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol. 2010;126:690-699.
20. Ishizuka T, Hisada T, Aoki H, Yanagitani N, Kaira K, Utsugi M, Shimizu Y, Sunaga N, Dobashi K, and Mori M: Gender and age risks for horseness and dysphonia with use of a dry powder fluticasone propionate inhaler in asthma. Allergy Asthma Proc. 2007;28:550-556.
21. GINA executive and science committees: Asthma Treatments: Global Strategy for Asthma Management and Prevention 2008 (Updated). Tacoma, WA: 2006 Medical Communications Resources, Inc.; pp. 27-48, 2008.
22. Tohda Y, Kubo H, Iwanaga K, Muraki M, Miyara T, and Sano H: (Title in English is not available.) Allergol Immunol. 2006;13:716-722 (in Japanese).
23. Akiyama K, and Ohta K: (Title in English is not available.) Med Drug J. 2006;42:136-145 (in Japanese).